Chinese botanicals & hepatotoxicity
This article was originally published in The Tan Sheet
Synthetic chemical N-nitroso-fenfluramine may be responsible for poisoning livers of 12 patients in Japan who took Chaso or Onshido botanical supplements, Masayuki Adachi, MD, Keio University, Tokyo, et al. report in September Annals of Internal Medicine. Record review of 12 patients revealed symptoms including fatigue, appetite loss that appeared five to 40 days after ingestion. One patient died, while another received a liver transplant, Adachi et al. state. The other 10 patients' conditions improved. "Severity of hepatotoxicity does not seem to correlate with duration of use or the amount of product ingested," the researchers note. Adachi and colleagues suggest further toxicologic analysis of the Chinese botanicals...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”